Treatment of Secondary Hemophagocytic Lymphohistiocytosis Associated With Diffuse Large B-cell Lymphoma Using Loncastuximab Tesirine As Lymphoma-Directed Therapy.
Saved in:
| Title: | Treatment of Secondary Hemophagocytic Lymphohistiocytosis Associated With Diffuse Large B-cell Lymphoma Using Loncastuximab Tesirine As Lymphoma-Directed Therapy. |
|---|---|
| Authors: | Schieber T; Hematology/Oncology, The University of Kansas Cancer Center, Kansas City, USA., Snyder J; Hematology, The University of Kansas Cancer Center, Kansas City, USA., Lutfi F; Hematology, The University of Kansas Cancer Center, Kansas City, USA. |
| Source: | Cureus [Cureus] 2024 Sep 29; Vol. 16 (9), pp. e70450. Date of Electronic Publication: 2024 Sep 29 (Print Publication: 2024). |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Cureus, Inc Country of Publication: United States NLM ID: 101596737 Publication Model: eCollection Cited Medium: Print ISSN: 2168-8184 (Print) Linking ISSN: 21688184 NLM ISO Abbreviation: Cureus Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
